ASCO Annual Meeting: New Approaches For Treatment of Hematologic Malignancies
ASCO Updates Guideline On Antiemetics
New Drug Combination Shrinks Kidney Cancers
Docetaxel, Oxaliplatin Active Against Esophageal Cancer
BRCA2 Carriers Reduced BC Risk By Prophylactic Surgery
Communication Is Key To Clinical Trial Enrollment
FDA Approves Treatment For Late-Stage Cervical Cancer
NCI-Approved Clinical Trials
Trending Stories
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- What NHS-Galleri taught us—and what it didn’t
- The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
- FDA clears a way for dramatic reduction in animal toxicology studies in cancer
- Is psilocybin heading to a cancer clinic near you?
Reversing Nixon-era taboo, Trump orders FDA to fast-track psychedelics and ARPA-H to fund research - As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded









